The economic case is compelling: returns on investment for every child vaccinated are huge. Every $1 spent on vaccines brings a 16-fold return on investment — this climbs to a return of $44 for every $1 spent if we look at all the extended benefits that vaccination brings.
Procuring medicines is not enough to make them available to the last mile. When functioning and fully funded public health supply chains are in place, the population, especially the most vulnerable, will receive the medicines when and where they need them.
AIDSFree has officially launched its newest web resource: the Viral Load (VL) and Early Infant Diagnosis (EID) Knowledge Base. Both VL testing and EID are essential to achieving 90-90-90 goals at country and global levels. The new resource, developed in consultation with clinicians and experts in logistics and lab management at USAID, serves as a one-stop resource for information on these critical interventions
Learn what steps Timor-Leste and its partners took to be rated as the most improved of 188 nations in the health-related Sustainable Development Goals index for the period 2000-2015.
The Nepal experience has generated many lessons that JSI, in partnership with the Nepalese government, have used to provide guidance and technical assistance to governments around the world that are interested in the use of chlorhexidine.
When we first started this work (in Ethiopia) about seven years ago, when customers came to a warehouse in search of their medicines, the pharmacist had to run down to the warehouse to check if they had an item (it took too long to find the stock card). Now they can access the data the same way as my Walgreens pharmacist can. And they can look to see if the stock is available at any of the other warehouses (even if the nearest location might be a day away).
Like many Eastern European countries in the early 1990s, Romania had a history of low contraception use and a high rate of abortion. Starting in 1999, progress accelerated dramatically thanks to a number of critical and complementary interventions; a national health insurance scheme, the privatization of health providers, extensive policy change, training to enable more providers to offer family planning services, and a heavy focus on rural access.
We need to look at whether people have the right mix of incentives to avoid unhealthy lifestyle choices, and to access preventive health, such as vaccinating their children, using contraceptives for birth spacing or to avoid pregnancy, using condoms for disease prevention, and sleeping under bed nets in malarial zones. But just as importantly, we need to ensure that health care providers, both individual and institutional, have the right alignment of incentives to deliver high quality, affordable health services and pharmaceuticals.
Do we have anything to learn from the Cola supply chain? Certainly. Governments and others working to distribute health commodities can learn a lot from the private sector, which excels at finding innovative ways to reduce cost, improve efficiencies, plan effectively, create incentives, and motivate people.
Providing and maintaining continuous access to health products for the most difficult-to-reach populations necessitates the development of agile supply chains that rely on a multiplicity of partners and strategies to improve service delivery.